Nutrition and Physical Activity in Patients With Cerebrovascular Disease
Launched by MANON GANTENBEIN · Jun 16, 2010
Trial Information
Current as of October 15, 2025
Completed
Keywords
ClinConnect Summary
Quality of life in the elderly and their families is severely affected by stroke and cognitive dysfunction caused by atherosclerosis of the brain supplying arteries. Nutrition, namely a Mediterranean-style diet, nuts, soybean products, whole grain products, dark chocolate, fish oil and avoidance of salt, and regular physical activity play a major role in the prevention of these diseases. Data are available on cardiac patients, however little is known on cerebrovascular patients. The role of red wine in the protection of cerebrovascular disease is discussed; it may be simply an epiphenomenon...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • In- and outpatients of the Neurology Department of the CHL and their family members
- • Carotid atherosclerosis assessed by B-mode ultrasound of at least 20% lumen reduction
- • No acute stroke/TIA/amaurosis fugax (at least 3 months ago)
- • Temporal ultrasound window suitable for recording of the middle cerebral artery
- • Ability to give informed consent
- Exclusion Criteria:
- • No signed informed consent
- • patient not able to give informed consent
About Manon Gantenbein
Manon Gantenbein is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a focus on ethical practices and regulatory compliance, Gantenbein leads initiatives that encompass diverse therapeutic areas, ensuring rigorous methodologies and robust data collection. The organization's mission is to foster collaboration among stakeholders, including researchers, healthcare professionals, and patients, to facilitate the development of safe and effective treatments. Through a patient-centered approach, Manon Gantenbein aims to contribute significantly to the scientific community and enhance the quality of care in healthcare settings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Luxembourg, Luxembourg
Patients applied
Trial Officials
Dirk Droste, Pr, MD
Principal Investigator
Centre Hospitalier du Luxembourg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials